Current Status
Not Enrolled
Price
Free
Get Started
Course
Resources

Assessment of Biomarkers in Lysosomal Storage Diseases From a Mechanistic Approach

To obtain CME/CE credit, you must LOG-IN and ENROLL (click orange button at top of page)

Lysosomal & Rare Disorders Research & Treatment Center

Assessment of Biomarkers in Lysosomal Storage Diseases From a Mechanistic Approach

July 1, 2022 – July 1, 2023

Estimated time to complete: 1.0 hours

Activity Description

This CME activity highlights how treatment options for lysosomal storage disorders have created new phenotypes for this once terminal conditions. Understanding the ‘new normal’ for these conditions can help health care providers manage their patients more effectively.

Continuing Education Information

This continuing education activity is provided through collaboration between Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare, and AffinityCE. This activity provides continuing education credit for Physicians, Physician Assistants, Nurse Practitioners, Nurses, Genetic Counselors as well as a statement of participation for other participants.

Faculty

Ozlem Goker-Alpan, MD
Co-founder and President
Lysosomal & Rare Disorders Research & Treatment Center (LDRTC)

Learning Outcomes

At the end of this activity, participants should be able to:

  • Describe advantages of biomarkers for LSDs
  • Describe the limitations of biomarkers LSDs
  • Describe why newer, more targeted biomarkers for LSDs are needed

Disclosures

AffinityCE, LDRTC, and CheckRare CE staff, as well as planning and review committees, have no financial interests to disclose and do not recommend the use of products outside of the FDA approved labelling.

Faculty Educators

Ozlem Goker-Alpan, MD is a consultant, a principal investigator and /or on the speaker bureau, or has received grant support from the following pharmaceutical companies: Actelion, Amicus Therapeutics, Genzyme Inc., Shire HGT, Pfizer/Protalix

Any conflict of interest for Dr. Goker-Alpan was resolved through peer review of content by a non-conflicted reviewer.

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 1 hour of AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 1 hour of AMA PRA Category 1 Credit™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Continuing Nursing Education is provided for this program through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides a maximum of 1 hour of continuing nursing education credit.

Nurse Practitioners

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 1 hour of AMA PRA Category 1 Credit™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.

Genetic Counselors

Category 2 CEU

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 1 hour of AMA PRA Category 1 Credit™. This activity meets Category 2 CEUs requirements of the National Society of Genetic Counselors (NCGC).

Other Professionals

All other health care professionals completing this continuing education activity will be issued a Statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

Commercial Support

Educational Support for this activity was provided by Takeda, Sanofi, and Chiesi.

Participation Costs

There is no cost to participate in these CE sessions.

CME Inquiries

For all CME policy-related inquiries, please contact us at ce@affinityced.com.
Send customer support requests to cds_support+ldrtc@affinityced.com.

Assessment of Biomarkers in Lysosomal Storage Diseases From a Mechanistic Approach

Slides

Transcripts